Phase 2–4 trials
Cardiomyopathy & ATTR amyloidosis · Live ClinicalTrials.gov data
Acoramidis (Attruby) clinical trial pipeline
ClinicalTrials.gov lists 10 phase 2–4 trials for acoramidis (Attruby), 4 of them actively recruiting. The next phase 3 primary completion among them is expected Apr 2028. Refreshed daily. Add up to four competitors to compare pipelines side by side.
Phase 3 trials
Actively recruiting
Next phase 3 primary completion
Participants across trials
Lead sponsor by trial count
acoramidis
Upcoming readouts
6 ahead · acoramidis
Key acoramidis trials
Top 10 of the 10 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track acoramidis with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for acoramidis?
- ClinicalTrials.gov currently lists 10 phase 2–4 acoramidis trials: 1 phase 2, 6 phase 3, and 3 phase 4. 4 are actively recruiting.
- Are there clinical trials for Attruby?
- Attruby is the brand name for acoramidis, so acoramidis trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 10 phase 2–4 acoramidis trials: 1 phase 2, 6 phase 3, and 3 phase 4. 4 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare acoramidis against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
